Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enhertu
Pharma
Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia
Merck and Kelun's sac-TMT reported three positive phase 3s. Experts talk useful tools in China dealmaking. Takeda was hit with a pay-for-delay verdict.
Angus Liu
May 22, 2026 8:53am
Enhertu secures dual FDA approvals in early breast cancer
May 18, 2026 10:52am
Daiichi Sankyo targets global top 5 oncology rank by 2035
May 11, 2026 10:22am
Daiichi Sankyo takes $610M hit tied to ADC manufacturing losses
May 8, 2026 10:47am
Daiichi Sankyo plots $1.5B consumer health unit sale to Suntory
Apr 15, 2026 3:22pm
China indicts AstraZeneca and former exec Leon Wang
Feb 11, 2026 11:13am
